RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyst reports?!jfm1330 wrote: As always the market is not giving much in advance to Thera. Skepticism is still there because of its history. This stock has been at 13.50$ many years ago and it fell down to pennies. It is hard to totally escape your history. If it would not be called Thera it would already be at 20$ just on the huge profit potential, but its called Thera. I think the company is near the time it will finally escape its history, but we are not there yet. This day will be linked to real profits. The old "show me the money" thing. As I said many times here, not only will it beat its history, but one day it will become overvalued. That's the way these markets work. So much is based on trust and for some, this incredible Ibalizumab deal and the approval are still not enough. They want to see the money.
Agreed, but the market will also be keeping an eye on Taimed this time around.
Investors in Taimed are not jaded and may push it quite high.
The arb opportunity will surely be exploited by someone with TH....evenutally.
bfw